Kistler-Tiffany Companies’s DexCom DXCM Stock Holding History

Kistler-Tiffany Companies’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$27.5K	Hold	214	–	–	﹤0.01%	576
2023 Q1	$24.9K	Hold	214	–	–	﹤0.01%	523
2022 Q4	$24.2K	Buy	214 +150	+234%	+$16.5K	0.01%	504
2022 Q3	$5K	Hold	64	–	–	﹤0.01%	674
2022 Q2	$5K	Hold	64	–	–	﹤0.01%	661
2022 Q1	$8K	Hold	64	–	–	﹤0.01%	619
2021 Q4	$9K	Hold	64	–	–	﹤0.01%	602
2021 Q3	$9K	Sell	64 -20	-24%	-$2.52K	﹤0.01%	596
2021 Q2	$9K	Hold	84	–	–	﹤0.01%	571
2021 Q1	$8K	Hold	84	–	–	﹤0.01%	543
2020 Q4	$8K	Hold	84	–	–	﹤0.01%	516
2020 Q3	$9K	Hold	84	–	–	﹤0.01%	485
2020 Q2	$9K	Buy	+84	New	+$7.51K	﹤0.01%	457

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Kistler-Tiffany Companies's DXCM Position: Q2 2023 in Review

Kistler-Tiffany Companies held its DexCom (DXCM) position steady in Q2 2023 at 214 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #576.

Kistler-Tiffany Companies first reported a position in DXCM in Q2 2020 and has held it in 13 quarters since. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

Kistler-Tiffany Companies held 214 shares of DexCom worth $27.5K as of Q2 2023.
Kistler-Tiffany Companies left its DexCom share count unchanged in Q2 2023.
DexCom made up ﹤0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #576 holding.
Kistler-Tiffany Companies first reported a position in DexCom in Q2 2020 and has held it in 13 quarters since.
954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.